CEO & Co-Founder, AxialBridge

Jaspreet Grewal is a globally connected leader at the intersection of clinical medicine, venture development, and life sciences innovation. As CEO and Co-Founder of AxialBridge, she is driving a mission to accelerate the growth of life sciences ecosystems across North America and Europe—supporting innovators, investors, and health systems in unlocking transformative impact through strategic partnerships and translational alignment.

Originally trained as a physician, Jaspreet’s career spans nearly two decades across the biotech, medtech, and digital health sectors. Her path has included work in clinical development, regulatory strategy, and go-to-market planning, with a particular focus on bridging early-stage science with commercial reality. She has advised national health bodies, venture firms, and scale-ups, bringing a uniquely integrated understanding of the challenges innovators face—from lab bench to patient bedside.

At AxialBridge, Jaspreet leads efforts to connect international capital with high-potential science, helping regional ecosystems—from Canada and the US to the UK and EU—position their innovation assets for global success. Her work blends deep sector knowledge with systems-level thinking, and a passion for equitable, scalable innovation.

At RetInnovate, Jaspreet contributes strategic insight into how breakthrough ideas can gain early market traction, attract investment, and align with healthcare needs. Her ability to connect the dots between science, policy, and capital makes her an invaluable voice in helping early-stage ventures plan smarter and scale with confidence.